Farallon Capital Management as of Sept. 30, 2018
Portfolio Holdings for Farallon Capital Management
Farallon Capital Management holds 102 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf (SPY) | 15.9 | $2.7B | 9.3M | 290.72 | |
| Aetna | 8.9 | $1.5B | 7.4M | 202.85 | |
| Altaba | 8.6 | $1.4B | 21M | 68.12 | |
| Express Scripts Holding | 6.7 | $1.1B | 12M | 95.01 | |
| Dell Technologies Inc Class V equity | 3.7 | $621M | 6.4M | 97.12 | |
| Rockwell Collins | 3.5 | $584M | 4.2M | 140.47 | |
| Facebook Inc cl a (META) | 2.4 | $409M | 2.5M | 164.46 | |
| Iqvia Holdings (IQV) | 2.3 | $394M | 3.0M | 129.74 | |
| Charter Communications Inc New Cl A cl a (CHTR) | 2.3 | $386M | 1.2M | 325.88 | |
| Alphabet Inc Class C cs (GOOG) | 2.2 | $376M | 315k | 1193.47 | |
| Wabtec Corporation (WAB) | 2.2 | $367M | 3.5M | 104.88 | |
| General Dynamics Corporation (GD) | 2.1 | $363M | 1.8M | 204.72 | |
| Visa (V) | 1.8 | $296M | 2.0M | 150.09 | |
| Playa Hotels & Resorts Nv (PLYA) | 1.7 | $295M | 31M | 9.63 | |
| Tilray (TLRY) | 1.7 | $286M | 2.5M | 115.14 | |
| Anthem (ELV) | 1.7 | $284M | 1.0M | 274.05 | |
| Ihs Markit | 1.6 | $273M | 5.1M | 53.96 | |
| Equinix (EQIX) | 1.6 | $264M | 609k | 432.89 | |
| Envision Healthcare | 1.5 | $257M | 5.6M | 45.73 | |
| Booking Holdings (BKNG) | 1.5 | $255M | 128k | 1984.00 | |
| Transunion (TRU) | 1.5 | $252M | 3.4M | 73.58 | |
| Microsoft Corporation (MSFT) | 1.5 | $247M | 2.2M | 114.37 | |
| Fox News | 1.4 | $246M | 5.4M | 45.82 | |
| Fidelity National Information Services (FIS) | 1.3 | $214M | 2.0M | 109.07 | |
| Citrix Systems | 1.2 | $202M | 1.8M | 111.16 | |
| Liberty Global Inc C | 1.2 | $197M | 7.0M | 28.16 | |
| Liberty Global Inc Com Ser A | 1.1 | $192M | 6.6M | 28.93 | |
| Verisk Analytics (VRSK) | 1.0 | $172M | 1.4M | 120.55 | |
| Brookfield Property Reit Inc cl a | 1.0 | $169M | 8.1M | 20.93 | |
| Nxp Semiconductors N V (NXPI) | 0.8 | $141M | 1.7M | 85.50 | |
| AstraZeneca (AZN) | 0.8 | $135M | 3.4M | 39.57 | |
| Equifax (EFX) | 0.6 | $107M | 816k | 130.57 | |
| Acceleron Pharma | 0.6 | $105M | 1.8M | 57.23 | |
| Ascendis Pharma A S (ASND) | 0.6 | $103M | 1.5M | 70.86 | |
| Myokardia | 0.6 | $100M | 1.5M | 65.20 | |
| Zogenix | 0.5 | $89M | 1.8M | 49.60 | |
| Sage Therapeutics (SAGE) | 0.5 | $88M | 625k | 141.25 | |
| Fibrogen (FGEN) | 0.5 | $85M | 1.4M | 60.75 | |
| Sina Corporation | 0.5 | $78M | 1.1M | 69.48 | |
| Array BioPharma | 0.5 | $78M | 5.1M | 15.20 | |
| Avista Corporation (AVA) | 0.4 | $74M | 1.5M | 50.56 | |
| Enanta Pharmaceuticals (ENTA) | 0.4 | $74M | 868k | 85.46 | |
| Novocure Ltd ord (NVCR) | 0.4 | $71M | 1.4M | 52.40 | |
| Twenty-first Century Fox | 0.4 | $67M | 1.4M | 46.33 | |
| Ca | 0.4 | $61M | 1.4M | 44.15 | |
| Alibaba Group Holding (BABA) | 0.4 | $62M | 373k | 164.76 | |
| Reata Pharmaceuticals Inc Cl A | 0.3 | $55M | 674k | 81.76 | |
| Amarin Corporation (AMRN) | 0.3 | $54M | 3.3M | 16.27 | |
| Global Blood Therapeutics In | 0.3 | $52M | 1.4M | 38.00 | |
| Iovance Biotherapeutics (IOVA) | 0.3 | $53M | 4.7M | 11.25 | |
| Crispr Therapeutics (CRSP) | 0.3 | $45M | 1.0M | 44.35 | |
| Mirati Therapeutics | 0.2 | $41M | 875k | 47.10 | |
| Grifols S A Sponsored Adr R (GRFS) | 0.2 | $38M | 1.8M | 21.37 | |
| Sutherland Asset Management reit | 0.2 | $37M | 2.2M | 16.65 | |
| Radius Health | 0.2 | $36M | 2.0M | 17.80 | |
| Sarepta Therapeutics (SRPT) | 0.2 | $32M | 195k | 161.51 | |
| Integrated Device Technology | 0.2 | $30M | 640k | 47.01 | |
| Savara (SVRA) | 0.2 | $27M | 2.4M | 11.16 | |
| Anheuser-Busch InBev NV (BUD) | 0.1 | $26M | 293k | 87.57 | |
| Alnylam Pharmaceuticals (ALNY) | 0.1 | $24M | 277k | 87.52 | |
| Protagonist Therapeutics (PTGX) | 0.1 | $23M | 2.2M | 10.29 | |
| Avrobio Ord (AVRO) | 0.1 | $24M | 465k | 51.87 | |
| Progenics Pharmaceuticals | 0.1 | $23M | 3.6M | 6.27 | |
| Ptc Therapeutics I (PTCT) | 0.1 | $20M | 420k | 47.00 | |
| Ptc Therapeutics Inc conv bd us | 0.1 | $21M | 18M | 1.15 | |
| Zymeworks | 0.1 | $21M | 1.3M | 15.70 | |
| Exelixis (EXEL) | 0.1 | $19M | 1.1M | 17.72 | |
| Puma Biotechnology (PBYI) | 0.1 | $19M | 410k | 45.85 | |
| Zafgen | 0.1 | $19M | 1.6M | 11.69 | |
| Aptinyx | 0.1 | $19M | 670k | 28.96 | |
| Codexis (CDXS) | 0.1 | $17M | 1.0M | 17.15 | |
| Brookfield Ppty Partners L P unit ltd partn | 0.1 | $17M | 794k | 20.89 | |
| Voyager Therapeutics (VYGR) | 0.1 | $17M | 909k | 18.92 | |
| Shire | 0.1 | $16M | 87k | 181.26 | |
| Chemocentryx | 0.1 | $15M | 1.2M | 12.64 | |
| Intellia Therapeutics (NTLA) | 0.1 | $16M | 550k | 28.62 | |
| Zealand Pharma A/s- | 0.1 | $15M | 900k | 16.52 | |
| Orbotech Ltd Com Stk | 0.1 | $14M | 230k | 59.44 | |
| Dynavax Technologies (DVAX) | 0.1 | $13M | 1.1M | 12.40 | |
| Bellicum Pharma | 0.1 | $13M | 2.1M | 6.16 | |
| Solid Biosciences | 0.1 | $14M | 295k | 47.18 | |
| Assembly Biosciences | 0.1 | $11M | 300k | 37.14 | |
| Coherus Biosciences (CHRS) | 0.1 | $12M | 700k | 16.50 | |
| Bemis Company | 0.1 | $10M | 207k | 48.60 | |
| Fate Therapeutics (FATE) | 0.1 | $8.6M | 530k | 16.29 | |
| Voya Financial (VOYA) | 0.1 | $9.2M | 185k | 49.67 | |
| Endocyte | 0.0 | $7.1M | 400k | 17.76 | |
| Solarcity Corp note 2.750%11/0 | 0.0 | $5.0M | 5.0M | 0.99 | |
| Intra Cellular Therapies (ITCI) | 0.0 | $5.4M | 250k | 21.70 | |
| Kalvista Pharmaceuticals (KALV) | 0.0 | $4.4M | 200k | 22.11 | |
| Translate Bio | 0.0 | $4.5M | 450k | 10.00 | |
| ArQule | 0.0 | $2.8M | 500k | 5.66 | |
| Spectrum Pharmaceuticals | 0.0 | $4.2M | 250k | 16.80 | |
| Sanofi Aventis Wi Conval Rt | 0.0 | $3.8M | 6.8M | 0.56 | |
| Pfenex | 0.0 | $3.1M | 600k | 5.11 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.0 | $4.1M | 142k | 28.65 | |
| Principia Biopharma | 0.0 | $3.7M | 125k | 29.22 | |
| Ra Med Sys | 0.0 | $2.7M | 150k | 18.20 | |
| Y Mabs Therapeutics (YMAB) | 0.0 | $3.3M | 125k | 26.56 | |
| Akorn | 0.0 | $909k | 70k | 12.99 | |
| Tyme Technologies | 0.0 | $1.1M | 406k | 2.78 | |
| Sutro Biopharma (STRO) | 0.0 | $2.3M | 150k | 15.00 |
